Biomedical research applications
Creators
Description
The biomedical research Panel believes that the Calutron facility at Oak Ridge is a national and international resource of immense scientific value and of fundamental importance to continued biomedical research. This resource is essential to the development of new isotope uses in biology and medicine. It should therefore be nurtured by adequate support and operated in a way that optimizes its services to the scientific and technological community. The Panel sees a continuing need for a reliable supply of a wide variety of enriched stable isotopes. The past and present utilization of stable isotopes in biomedical research is documented in Appendix 7. Future requirements for stable isotopes are impossible to document, however, because of the unpredictability of research itself. Nonetheless we expect the demand for isotopes to increase in parallel with the continuing expansion of biomedical research as a whole. There are a number of promising research projects at the present time, and these are expected to lead to an increase in production requirements. The Panel also believes that a high degree of priority should be given to replacing the supplies of the 65 isotopes (out of the 224 previously available enriched isotopes) no longer available from ORNL
Files
Additional details
Publishing Information
- Imprint Title
- Separated isotopes: vital tools for science and medicine
- Journal Page Range
- p. 23-27.
- Report number
- DOE/ER/10984--6
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 14723330
- Subject category
- S37: INORGANIC, ORGANIC, PHYSICAL AND ANALYTICAL CHEMISTRY; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DIAGNOSIS; ELECTROMAGNETIC ISOTOPE SEPARA; MEDICINE; ORNL; RADIOPHARMACEUTICALS; RESEARCH PROGRAMS; STABLE ISOTOPES; TRACER TECHNIQUES; USES
- Descriptors DEC
- DRUGS; ISOTOPE APPLICATIONS; ISOTOPE SEPARATION; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; NATIONAL ORGANIZATIONS; RADIOACTIVE MATERIALS; SEPARATION PROCESSES; US AEC; US ERDA; US ORGANIZATIONS